Nottingham, United Kingdom

Emma Blackham

USPTO Granted Patents = 2 


 

Average Co-Inventor Count = 3.4

ph-index = 1


Company Filing History:


Years Active: 2023-2024

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovator Spotlight: Emma Blackham and Her Contributions to Science

Introduction: Emma Blackham, a prominent inventor based in Nottingham, Great Britain, has made significant strides in the field of pharmaceutical innovations. With a total of two patents to her name, she is recognized for her valuable contributions to the understanding and development of compounds aimed at inhibiting CTPS1, a crucial enzyme in cellular metabolism.

Latest Patents: Emma's latest patents showcase her expertise and innovative approach in medicinal chemistry. The first patent, titled "Aminopyrimidine/pyrazine derivatives as CTPS1 inhibitors - Compounds of formula (I) and related aspects," introduces novel compounds that hold potential therapeutic benefits. The second patent, "Aminothiazole compounds as inhibitors of CTPS1 - Compounds of formula (I) and related aspects," further expands on her research, emphasizing the importance of these compounds in addressing metabolic disorders.

Career Highlights: Emma's professional journey is marked by her association with Step Pharma S.a.s., where she continues to push the boundaries of drug discovery and development. Her dedication to advancing science is evident through her innovative research and commitment to improving healthcare solutions.

Collaborations: Collaboration is essential in the world of innovation, and Emma works alongside esteemed colleagues, including Abdul Quddus and Andrew Richard Novak. Together, they combine their expertise to explore new frontiers in pharmaceutical research, contributing to a collaborative environment that fosters creativity and progress.

Conclusion: Emma Blackham stands out as a skilled inventor whose work has the potential to impact health and medicine significantly. With her patents focusing on critical inhibitors of CTPS1, she embodies the spirit of innovation and dedication to advancing scientific knowledge. As her career unfolds, the contributions of Emma Blackham will undoubtedly continue to shape the future of pharmaceutical research.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…